|
1
|
Fu R, Liu H, Wang Y, Liu H, He H, Chen J,
Wang H, Yu H, Ding K, Huang L, et al: Distinguishing immunorelated
haemocytopenia from idiopathic cytopenia of undetermined
significance (ICUS): A bone marrow abnormality mediated by
autoantibodies. Clin Exp Immunol. 177:412–418. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
He H, Shao Z and Cao Z: Bone marrow
mononuclear Coombs test. Chin J Hematol. 21:550–551. 2000.
|
|
3
|
Sun J, Cao Z and Tu F: Modified direct
antiglobulin test. Chin J Laborat Med. 26:12–14. 2006.
|
|
4
|
Wang YH, Fu R, Dong SW, Liu H and Shao ZH:
Erythroblastic islands in the bone marrow of patients with
immune-related pancytopenia. PLoS One. 9:e951432014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu H, Fu R, Wang Y, Liu H, Li L, Wang H,
Chen J, Yu H and Shao Z: Detection and analysis of autoantigens
targeted by autoantibodies in immunorelated pancytopenia. Clin Dev
Immunol. 2013:2976782013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang YH, Fu R, Shao ZH, Wang HQ, Xing LM,
Liu H, Wu YH, Li LJ, Liu H, Wang J, et al: Study on quantity and
function of bone marrow macrophages in patients with BMMNC-Coombs
Test(+) pancytopenia. Zhonghua Xue Ye Xue Za Zhi. 30:538–542.
2009.(In Chinese). PubMed/NCBI
|
|
7
|
Chen J, Fu R, Li LJ, Liu H, Wang YH, Wang
HL and Shao ZH: Variation in complement level and its significance
in cytopenia patients with positive BMMNC-Coombs. Zhonghua Xue Ye
Xue Za Zhi. 30:454–457. 2009.(In Chinese). PubMed/NCBI
|
|
8
|
Fu R, Liu H, Wang J, Li LJ, Wang HL, Wang
YH and Shao ZH: Preliminary study of autoantigens on the membrane
of erythropoietic cells of the patients with BMMNC-Coomb's test(+)
hemocytopenia. Zhonghua Yi Xue Za Zhi. 92:2689–2693. 2012.(In
Chinese). PubMed/NCBI
|
|
9
|
Fu R, Shao Z, He H, Liu H, Jia H, Sun J,
Zhao M, He G, Shi J, Bai J, et al: Quantity and apoptosis-related
protein level of B lymphocyte in patients with immunorelated
pancytopenia. Zhonghua Xue Ye Xue Za Zhi. 23:236–238. 2002.(In
Chinese). PubMed/NCBI
|
|
10
|
Wang Y, Fu R, Liu H, Wang H, Zhang T, Ding
S, Zhang J, Gao S, Liu C, Wang J, et al: Memory B (CD5+
CD19+ CD27+) lymphocyte in patients with
immune-related pancytopenia. Zhonghua Xue Ye Xue Za Zhi.
35:719–723. 2014.(In Chinese). PubMed/NCBI
|
|
11
|
Raphael I and Forsthuber TG: Stability of
T-cell lineages in autoimmune diseases. Expert Rev Clin Immunol.
8:299–301. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Raphael I, Nalawade S, Eagar TN and
Forsthuber TG: T cell subsets and their signature cytokines in
autoimmune and inflammatory diseases. Cytokine. 74:5–17. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park H, Li Z, Yang XO, Chang SH, Nurieva
R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q and Dong C: A distinct
lineage of CD4 T cells regulates tissue inflammation by producing
interleukin 17. Nat Immunol. 6:1133–1141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harrington LE, Hatton RD, Mangan PR,
Turner H, Murphy TL, Murphy KM and Weaver CT: Interleukin
17-producing CD4+ effector T cells develop via a lineage
distinct from the T helper type 1 and 2 lineages. Nat Immunol.
6:1123–1132. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miyara M and Sakaguchi S: Natural
regulatory T cells: Mechanisms of suppression. Trends Mol Med.
13:108–116. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fu R, Wang HL, Chen J, Wang J, Li LJ, Liu
H, Wang YH, Ren Y and Shao ZH: Study of the quantity and function
of Th17 cells in the blood cytopenic patients with positive
BMMNC-Coombs test. Zhonghua Xue Ye Xue Za Zhi. 31:684–687. 2010.(In
Chinese). PubMed/NCBI
|
|
17
|
Fu R, Chen J, Wang HL, Wang J, Li LJ, Liu
H, Wang YH, Ren Y and Shao ZH: Quantity and function of regulatory
T cells in hemocytopenic patients with positive BMMNC-Coombs test.
Zhonghua Yi Xue Za Zhi. 90:2989–2993. 2010.(In Chinese). PubMed/NCBI
|
|
18
|
Yu H, Zhang J, Fu R, Liu H, Wang H, Ding
K, Wang Y, Li L, Wang H and Shao Z: Increased frequency of bone
marrow T follicular helper cells in patients with immune-related
pancytopenia. Clin Dev Immunol. 2013:7304502013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu X, Guan J, Xu J, Wei J, Jiang L, Yin
J, Zhao L and Zhang Y: Pilot study using tacrolimus rather than
cyclosporine plus antithymocyte globulin as an immunosuppressive
therapy regimen option for severe aplastic anemia in adults. Blood
Cells Mol Dis. 53:157–160. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Heinzel FP, Sadick MD, Holaday BJ, Coffman
RL and Locksley RM: Reciprocal expression of interferon gamma or
interleukin 4 during the resolution or progression of murine
leishmaniasis. Evidence for expansion of distinct helper T cell
subsets. J Exp Med. 169:59–72. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hori S, Nomura T and Sakaguchi S: Control
of regulatory T cell development by the transcription factor Foxp3.
Science. 299:1057–1061. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mattozzi C, Salvi M, D'Epiro S,
Giancristoforo S, Macaluso L, Luci C, Lal K, Calvieri S and
Richetta AG: Importance of regulatory T cells in the pathogenesis
of psoriasis: Review of the literature. Dermatology. 227:134–145.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu D, Liu H, Komai-Koma M, Campbell C,
McSharry C, Alexander J and Liew FY:
CD4+CD25+ regulatory T cells suppress
differentiation and functions of Th1 and Th2 cells, Leishmania
major infection, and colitis in mice. J Immunol. 170:394–399.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sakaguchi S, Ono M, Setoguchi R, Yagi H,
Hori S, Fehervari Z, Shimizu J, Takahashi T and Nomura T:
Foxp3+ CD25+ CD4+ natural
regulatory T cells in dominant self-tolerance and autoimmune
disease. Immunol Rev. 212:8–27. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim HP, Kelly J and Leonard WJ: The basis
for IL-2-induced IL-2 receptor alpha chain gene regulation:
Importance of two widely separated IL-2 response elements.
Immunity. 15:159–172. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Setoguchi R, Hori S, Takahashi T and
Sakaguchi S: Homeostatic maintenance of natural Foxp3(+) CD25(+)
CD4(+) regulatory T cells by interleukin (IL)-2 and induction of
autoimmune disease by IL-2 neutralization. J Exp Med. 201:723–735.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Y, Zhang P, Li J, Kulkarni AB,
Perruche S and Chen W: A critical function for TGF-beta signaling
in the development of natural
CD4+CD25+Foxp3+ regulatory T
cells. Nat Immunol. 9:632–640. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nakamura K, Kitani A and Strober W: Cell
contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T
cells is mediated by cell surface-bound transforming growth factor
beta. J Exp Med. 194:629–644. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakano S, Morimoto S, Suzuki S, Tsushima
H, Yamanaka K, Sekigawa I and Takasaki Y: Immunoregulatory role of
IL-35 in T cells of patients with rheumatoid arthritis.
Rheumatology (Oxford). 54:1498–1506. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mangan PR, Harrington LE, O'Quinn DB,
Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR and
Weaver CT: Transforming growth factor-beta induces development of
the T(H)17 lineage. Nature. 441:231–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Eddahri F, Denanglaire S, Bureau F,
Spolski R, Leonard WJ, Leo O and Andris F: Interleukin-6/STAT3
signaling regulates the ability of naive T cells to acquire B-cell
help capacities. Blood. 113:2426–2433. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin FJ, Jiang GR, Shan JP, Zhu C, Zou J
and Wu XR: Imbalance of regulatory T cells to Th17 cells in IgA
nephropathy. Scand J Clin Lab Invest. 72:221–229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ooi JD, Kitching AR and Holdsworth SR:
Review: T helper 17 cells: Their role in glomerulonephritis.
Nephrology (Carlton). 15:513–521. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stangou M, Bantis C, Skoularopoulou M,
Korelidou L, Kouloukouriotou D, Scina M, Labropoulou IT, Kouri NM,
Papagianni A and Efstratiadis G: Th1, Th2 and Treg/T17 cytokines in
two types of proliferative glomerulonephritis. Indian J Nephrol.
26:159–166. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Aggarwal S, Ghilardi N, Xie MH, de Sauvage
FJ and Gurney AL: Interleukin-23 promotes a distinct CD4 T cell
activation state characterized by the production of interleukin-17.
J Biol Chem. 278:1910–1914. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Croxford AL, Mair F and Becher B: IL-23:
One cytokine in control of autoimmunity. Eur J Immunol.
42:2263–2273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Olewicz-Gawlik A, Danczak-Pazdrowska A,
Kuznar-Kaminska B, Gornowicz-Porowska J, Katulska K, Trzybulska D,
Batura-Gabryel H, Silny W, Poplawski D and Hrycaj P: Interleukin-17
and interleukin-23: importance in the pathogenesis of lung
impairment in patients with systemic sclerosis. Int J Rheum Dis.
17:664–670. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ouyang H, Shi Y, Liu Z, Feng S, Li L, Su
N, Lu Y and Kong S: Increased interleukin-9 and
CD4+IL-9+ T cells in patients with systemic
lupus erythematosus. Mol Med Rep. 7:1031–1037. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Masuda M, Matsumoto M, Tanaka S, Nakajima
K, Yamada N, Ido N, Ohtsuka T, Nishida M, Hirano T and Utsumi H:
Clinical implication of peripheral CD4+CD25+
regulatory T cells and Th17 cells in myasthenia gravis patients. J
Neuroimmunol. 225:123–131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ishihara K and Hirano T: IL-6 in
autoimmune disease and chronic inflammatory proliferative disease.
Cytokine Growth Factor Rev. 13:357–368. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Aricha R, Mizrachi K, Fuchs S and
Souroujon MC: Blocking of IL-6 suppresses experimental autoimmune
myasthenia gravis. J Autoimmun. 36:135–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fu R and Shao Z: Immuno-related
pancytopenia: A newly recognized disease (part 1). Chin J Med.
40:5–8. 2005.
|
|
43
|
Enghard P, Humrich J, Chu VT, Grussie E,
Hiepe F, Burmester GR, Radbruch A, Berek C and Riemekasten G: Class
switching and consecutive loss of dsDNA-reactive B1a B cells from
the peritoneal cavity during murine lupus development. Eur J
Immunol. 40:1809–1818. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhong X, Gao W, Degauque N, Bai C, Lu Y,
Kenny J, Oukka M, Strom TB and Rothstein TL: Reciprocal generation
of Th1/Th17 and T(reg) cells by B1 and B2 B cells. Eur J Immunol.
37:2400–2404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhong X, Lau S, Bai C, Degauque N,
Holodick NE, Steven SJ, Tumang J, Gao W and Rothstein TL: A novel
subpopulation of B-1 cells is enriched with autoreactivity in
normal and lupus-prone mice. Arthritis Rheum. 60:3734–3743. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Maseda D, Candando KM, Smith SH,
Kalampokis I, Weaver CT, Plevy SE, Poe JC and Tedder TF: Peritoneal
cavity regulatory B cells (B10 cells) modulate
IFN-γ+CD4+ T cell numbers during colitis
development in mice. J Immunol. 191:2780–2795. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Shao Y, Fu R, Liu H, Wang Y, Ding S, Wang
H, Li L and Shao Z: IgG autoantibody subclasses altered in
immuno-related hemocytopenia. Cell Immunol. 294:13–20. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wu YY, Georg I, Díaz-Barreiro A, Varela N,
Lauwerys B, Kumar R, Bagavant H, Castillo-Martín M, El Salem F,
Marañón C and Alarcón-Riquelme ME: Concordance of increased B1 cell
subset and lupus phenotypes in mice and humans is dependent on BLK
expression levels. J Immunol. 194:5692–5702. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Deng J, Wang X, Chen Q, Sun X, Xiao F, Ko
KH, Zhang M and Lu L: B1a cells play a pathogenic role in the
development of autoimmune arthritis. Oncotarget. 7:19299–19311.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Flores-Borja F, Bosma A, Ng D, Reddy V,
Ehrenstein MR, Isenberg DA and Mauri C:
CD19+CD24hiCD38hi B cells maintain regulatory T cells
while limiting TH1 and TH17 differentiation. Sci Transl Med.
5:173ra232013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Blair PA, Noreña LY, Flores-Borja F,
Rawlings DJ, Isenberg DA, Ehrenstein MR and Mauri C:
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in
healthy individuals but are functionally impaired in systemic Lupus
Erythematosus patients. Immunity. 32:129–140. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Georgin-Lavialle S, Aouba A, Mouthon L,
Londono-Vallejo JA, Lepelletier Y, Gabet AS and Hermine O: The
telomere/telomerase system in autoimmune and systemic
immune-mediated diseases. Autoimmun Rev. 9:646–651. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Fujii H, Shao L, Colmegna I, Goronzy JJ
and Weyand CM: Telomerase insufficiency in rheumatoid arthritis.
Proc Natl Acad Sci USA. 106:4360–4365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hoffecker BM, Raffield LM, Kamen DL and
Nowling TK: Systemic lupus erythematosus and vitamin D deficiency
are associated with shorter telomere length among African
Americans: A case-control study. PLoS One. 8:e637252013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wu K, Higashi N, Hansen ER, Lund M, Bang K
and Thestrup-Pedersen K: Telomerase activity is increased and
telomere length shortened in T cells from blood of patients with
atopic dermatitis and psoriasis. J Immunol. 165:4742–4747. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Son NH, Murray S, Yanovski J, Hodes RJ and
Weng N: Lineage-specific telomere shortening and unaltered capacity
for telomerase expression in human T and B lymphocytes with age. J
Immunol. 165:1191–1196. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
King C, Tangye SG and Mackay CR: T
follicular helper (TFH) cells in normal and dysregulated immune
responses. Annu Rev Immunol. 26:741–766. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lüthje K, Kallies A, Shimohakamada Y, Belz
GT, Light A, Tarlinton DM and Nutt SL: The development and fate of
follicular helper T cells defined by an IL-21 reporter mouse. Nat
Immunol. 13:491–498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Jabeen R, Goswami R, Awe O, Kulkarni A,
Nguyen ET, Attenasio A, Walsh D, Olson MR, Kim MH, Tepper RS, et
al: Th9 cell development requires a BATF-regulated transcriptional
network. J Clin Invest. 123:4641–4653. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Eyerich S, Eyerich K, Pennino D, Carbone
T, Nasorri F, Pallotta S, Cianfarani F, Odorisio T, Traidl-Hoffmann
C, et al: Th22 cells represent a distinct human T cell subset
involved in epidermal immunity and remodeling. J Clin Invest.
119:3573–3585. 2009.PubMed/NCBI
|
|
61
|
Fallon PG, Ballantyne SJ, Mangan NE,
Barlow JL, Dasvarma A, Hewett DR, McIlgorm A, Jolin HE and McKenzie
AN: Identification of an interleukin (IL)-25-dependent cell
population that provides IL-4, IL-5, and IL-13 at the onset of
helminth expulsion. J Exp Med. 203:1105–1116. 2006. View Article : Google Scholar : PubMed/NCBI
|
